Neonatal Ventilators Market Size, Share, and Trends 2024 to 2034

The global neonatal ventilators market size was USD 427.41 million in 2023, calculated at USD 457.84 million in 2024 and is expected to be worth around USD 910.80 million by 2034. The market is slated to expand at 7.12% CAGR from 2024 to 2034

  • Last Updated : September 2024
  • Report Code : 4956
  • Category : Healthcare

Neonatal Ventilators Market Size and Forecast 2024 to 2034

The global neonatal ventilators market size is expected to worth USD 457.84 million in 2024 and is anticipated to reach around USD 910.80 million by 2034, growing at a CAGR of 7.12% over the forecast period 2024 to 2034.

Neonatal Ventilators Market Size 2024 to 2034

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Neonatal Ventilators Market Key Takeaways

  • North America dominated the neonatal ventilators market with the largest market share of 47% in 2023.
  • Asia Pacific is observed to be the fastest growing in the neonatal ventilators market during the forecast period.
  • By product, the invasive ventilation segment dominated the neonatal ventilators market in 2023.
  • By product, the non-invasive ventilation segment is observed to be the fastest growing in the market during the forecast period.
  • By mobility, the intensive care ventilators segment dominated the neonatal ventilators market in 2023.
  • By mobility, the portable/transportable ventilators segment contributed the highest market share of 67% in 2023.
  • By technology, the high frequency ventilators segment dominated the neonatal ventilators market in 2023.
  • By technology, the mechanical ventilators segment shows notable growth in the neonatal ventilators market during the forecast period.
  • By mode, the combined mode segment dominated the neonatal ventilators market in 2023.
  • By end-use, the hospitals segment dominated the neonatal ventilators market in 2023.
  • By end-use, the clinics segment is observed to be the fastest growing in the market during the forecast period.

U.S. Neonatal Ventilators Market Size and Growth 2024 to 2034

The U.S. neonatal ventilators market size was reached at USD 140.62 million in 2023 and is projected to be worth around USD 305 million by 2034, poised to grow at a CAGR of 7.29% from 2024 to 2034.

U.S. Neonatal Ventilators Market Size 2024 to 2034

North America dominated in the neonatal ventilators market in 2023. North America has a vast network of modern hospitals and newborn care units. Modern medical equipment, such as neonatal ventilators, essential for treating premature or seriously sick infants, is readily available in these clinics. In North America, preterm birth rates are comparatively high. Because they are necessary for the care of premature infants, neonatal ventilators are in greater demand in the area. Neonatal ventilator demand is further driven by funding for neonatal care programs and supportive healthcare policy.

  • In May 2024, The Health Care Service Corporation will offer more assistance and resources to improve the health of mothers and infants in Illinois significantly. By expanding access to care, closing care gaps, and involving and educating the local population, the extended maternal and infant health effort seeks to enhance health outcomes.

Neonatal Ventilators Market Share, By Region, 2023 (%)

Asia-Pacific is observed to be the fastest growing in the neonatal ventilators market during the forecast period. Asia-Pacific has seen significant infrastructure investment in the healthcare sector. Modern ventilatory support systems are necessary in neonatal intensive care units (NICUs). Hence, governments and commercial groups concentrate on improving these facilities. Technology is advancing quickly in the neonatal ventilator industry, creating increasingly complex and user-friendly equipment. Novelties like noninvasive and portable ventilators are becoming more and more common, especially in developing nations with inadequate infrastructure.

Market Overview

The industry that manufactures, distributes, and uses ventilators intended for newborns and infants, especially those born prematurely or with respiratory problems, is known as the neonatal ventilators market. To ensure sufficient oxygenation and ventilation to avoid or manage respiratory distress and other related issues, these ventilators provide artificial ventilation to supplement or replace the baby's natural breathing processes.

By providing precise control over breathing parameters, these devices enhance clinical results and lower the risk of long-term respiratory and neurological impairment in neonates. Specialized ventilators are in high demand within the medical device sector due to the increasing rates of premature births and respiratory problems in neonates. The use of neonatal ventilators is essential for improving the survival rates of premature and seriously sick infants.

How is AI helping the ventilator industry’s growth?

Artificial intelligence (AI) has been used in neurocritical care to develop automated seizure detection algorithms and severity grading systems for hypoxic-ischemic encephalopathy based on electroencephalograms. Furthermore, the advancement of assessing the growing newborn brain and comprehending how prenatal events influence structural and functional network topologies has been made possible by AI models that analyze magnetic resonance imaging. AI algorithms have also been used to evaluate preterm infants' extubation readiness and forecast the onset of bronchopulmonary dysplasia. Retinopathy of prematurity has also been identified, and the necessity of treatment has been established using automated models.

Neonatal Ventilators Market Growth Factors

  • The market for neonatal ventilators is significantly influenced by the rising incidence of preterm births occurring worldwide. These babies need breathing support quite frequently.
  • The market is expanding due to rising awareness of newborn respiratory illnesses and easier access to medical facilities in developing nations.
  • The need for neonatal ventilators is rising due to improvements in neonatal care methods and technology that increase the survival rates of preterm and seriously sick neonates.
  • The market is driven by the development of noninvasive ventilation and smaller, more portable, and user-friendly neonatal ventilators with these characteristics.
  • Growing healthcare spending presents prospects for market expansion, especially in emerging markets.
  • Government assistance, including infrastructure development, healthcare legislation, and reimbursement schemes, is encouraging the expansion of the market.

Market Scope

Report Coverage Details
Market Size by 2034 USD 910.80 Million
Market Size in 2023 USD 457.84 Million
Market Size in 2024 USD 427.41 Million
Market Growth Rate from 2024 to 2034 CAGR of 7.12%
Largest Market North America
Base Year 2023
Forecast Period 2024 to 2034
Segments Covered Product, Mobility, Technology, Mode, End-use, and Regions
Regions Covered North America, Europe, Asia-Pacific, Latin America and Middle East & Africa

Market Dynamics

Drivers

Rising incidence of premature births globally

Around the world, the number of premature births has been increasing because of several reasons, including changing lifestyles, advancing assisted reproductive technologies, and older mothers. Neonatal care equipment is in greater demand as healthcare advances and more pregnancies are actively followed, resulting in an increased identification and management of premature babies. The early identification of high-risk pregnancies, made possible by improved prenatal care and early detection procedures, necessitates the use of newborn ventilators and prompt interventions.

Rise in respiratory disorders in newborns

High-frequency oscillatory ventilation (HFOV) and synchronized ventilation are two sophisticated characteristics of modern neonatal ventilators that are essential for handling complicated respiratory disorders. These innovations meet newborn-specific demands, enhance patient outcomes, and propel market expansion. Worldwide, the number of neonatal intensive care units (NICUs) has significantly increased due to the rising prevalence of respiratory diseases. Due to this increase, neonatal ventilators and other specialist equipment are in high demand.

Restraint

Inadequate healthcare infrastructure

There may not be enough neonatal intensive care units (NICUs) or other specialist institutions in areas lacking the infrastructure to provide for the needs of very sick babies. Since these hospitals are the primary consumers, the demand for newborn ventilators is limited. Distributing and maintaining neonatal ventilators might be logistically challenging in inadequate infrastructure. Inadequate supply chains and transportation networks can hamper the prompt delivery of these devices to areas in need.

Opportunity

Advances in neonatal care technology

EHR systems are becoming increasingly integrated with new newborn ventilators, enabling real-time data collecting and processing. This integration improves clinical decision-making overall and makes it easier to monitor patient progress and make timely adjustments to treatment regimens. Advanced alarm mechanisms on modern ventilators provide instant notifications when operating parameters depart from. These alerts guarantee timely reactions to altering patient situations and aid in averting possible complications.

Product Insights

The invasive ventilation segment dominated the neonatal ventilators market in 2023. Neonates experiencing severe respiratory distress or failure frequently require invasive ventilation, which entails endotracheal or tracheostomy tubes. Infants born prematurely or with congenital disabilities may have airway problems or underdeveloped lungs, which makes invasive support necessary to provide enough ventilation and oxygen. The significant training that healthcare practitioners receive in invasive ventilation techniques contributes to the increased use and acceptance of these devices. The knowledge found in NICUs further encourages the employment of invasive ventilation technology.

The non-invasive ventilation segment is observed to be the fastest growing in the neonatal ventilators market during the forecast period. Bilevel positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) are two examples of non-invasive breathing treatments that have gained popularity due to their many benefits. Among these advantages is a lower chance of intrusive procedure-related problems, including lung damage or infections. The use of NIV is growing as more healthcare providers become aware of these benefits.

Research has indicated that non-invasive ventilation can improve neonatal clinical outcomes, such as a decreased risk of bronchopulmonary dysplasia (BPD) and associated problems. As a result, NIV is now preferred for treating respiratory ailments, which has helped it expand in the market.

Mobility Insights

The intensive care ventilators segment dominated the neonatal ventilators market in 2023. Enhanced safety measures and advanced monitoring are vital for the management of critically ill newborns using intensive care ventilators. These include automated ventilation optimization modifications, alert systems, and real-time respiratory parameter monitoring. Accurate and timely care is crucial for infants with complicated medical issues, and these aspects help with that.

The portable/transportable ventilators segment shows notable growth in the neonatal ventilators market during the forecast period. Global preterm birth rates are rising, which is driving up demand for sophisticated neonatal care. These babies' breathing demands must be met, especially in an emergency or while being transported, and portable ventilators are crucial. The need for portable ventilators has increased due to establishing more neonatal intensive care units (NICUs) and specialized newborn transport services. To handle a range of clinical circumstances, these institutions frequently need different ventilatory support options, including portable models.

Technology Insights

The high frequency ventilators segment dominated the neonatal ventilators market in 2023. In contrast to traditional ventilators, high-frequency ventilators (HFVs) provide fast, small-volume breaths at high frequencies, usually between three and fifteen breaths per second. This high-frequency breathing offers sufficient respiratory support for infants, particularly those with severe respiratory distress or diseases such as Neonatal Respiratory Distress Syndrome (NRDS). Because of the tiny, regular breaths that reduce stress on the developing lungs of neonates and enhance gas exchange, HFVs are especially useful in treating severe respiratory disorders.

The mechanical ventilators segment shows notable growth in the neonatal ventilators market during the forecast period. Globally, preterm birth rates are rising, which is driving up the need for neonatal care. Mechanical ventilators are essential in the care of premature babies who frequently experience respiratory distress. Numerous nations are investing more in NICUs and other healthcare infrastructure. This expansion involves purchasing sophisticated mechanical ventilators to enhance infant care. Premature and low-birth-weight babies are more likely to suffer from conditions like Chronic Lung Disease (CLD) and respiratory distress syndrome (RDS). For these conditions to be adequately managed, mechanical ventilators are necessary.

Mode Insights

The combined mode segment dominated the neonatal ventilators market in 2023. Combined mode ventilators provide versatility in both traditional and enhanced ventilation modes. This flexibility enables medical professionals to customize ventilation plans to meet the unique requirements of every neonatal patient, regardless of whether they need synchronized intermittent mandatory ventilation (SIMV) or assist-control ventilation (AC), among other modes. In the quickly changing world of newborn care, this adaptability is essential. Ventilation settings may now be adjusted and managed more rapidly due to the intuitive user interfaces of combined mode ventilators. Because of its ease of use, healthcare professionals can make better clinical decisions and react swiftly to patients' evolving requirements.

End-use Insights

The hospitals segment dominated the neonatal ventilators market in 2023. When it comes to giving preterm and severely ill neonates breathing support, neonatal ventilators are essential. Advanced ventilatory support systems are necessary in hospitals, especially neonatal intensive care units (NICUs), which are suited to address severe medical problems. In these situations, neonatal ventilators are essential because of the increased demand for specialist treatment. Hospitals often see more newborn patients than in other healthcare settings like clinics or home care situations. Due to the increasing patient throughput, many neonatal ventilators are required to meet the demands of more patients at once.

The clinics segment is observed to be the fastest growing in the neonatal ventilators market during the forecast period. Due to rising birth rates, the need for newborn care services is growing in many areas. Worldwide, the number of preterm births is increasing. Clinics increasingly need to use sophisticated neonatal ventilators because premature babies frequently need specialized respiratory care. Greater neonatal ventilator training programs for medical staff increase clinic uptake and utilization. The increasing usage of modern neonatal ventilation technology in clinics can be attributed to increased awareness among healthcare providers of its advantages.

Neonatal Ventilators Market Companies

  • Air Liquide
  • Becton Dickinson
  • Breas Medical
  • Drägerwerk AG & Co. KGaA
  • Getinge Group
  • Medtronic plc
  • ICU Medical
  • GE Healthcare
  • HAMILTON MEDICAL
  • Koninklijke Philips N.V

Recent Developments

  • In June 2024, Health tech company C2-Ai has publicly introduced a new "observatory" system to assist hospitals in comprehending the risks, results, and safety associated with maternity and neonatal care.
  • In February 2024, to lower newborn mortality, the state health department in Karnataka initiated the first-ever Neonatal Intensive Care Unit (NICU) ambulance service. Children under five who require emergency care can be treated in neonatal ambulances.
  • In November 2023, The SLE1500 is the most recent model in Inspiration Healthcare's specialized neonatal ventilators, designed to provide the best possible care for neonates in critical condition.

Segments Covered in the Report 

By Product

  • Invasive Ventilation
  • Non-invasive Ventilation

By Mobility

  • Intensive Care Ventilators
  • Portable/Transportable Ventilators

By Technology

  • Mechanical Ventilators
  • High Frequency Ventilators
  • Volume Targeted Ventilators
  • Hybrid Ventilators

By Mode

  • Pressure Mode Ventilation
  • Combined Mode Ventilation
  • Volume Mode Ventilation
  • Other Modes

By End-use

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Other End-users

By Geography

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

The global neonatal ventilators market size is expected to increase USD 910.80 million by 2034 from USD 427.41 million in 2023.

The neonatal ventilators market is anticipated to grow at a CAGR of over 7.12% between 2024 and 2034.

The major players operating in the neonatal ventilators market are Air Liquide, Becton Dickinson, Breas Medical ,Drägerwerk AG & Co. KGaA, Getinge Group, Medtronic plc, ICU Medical, GE Healthcare, HAMILTON MEDICAL, Koninklijke, Philips N.V, and Others.

The driving factors of the neonatal ventilators market are the rising incidence of premature births globally and rise in respiratory disorders in newborns.

North America region will lead the global neonatal ventilators market during the forecast period 2024 to 2034.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Neonatal Ventilators Market 

5.1. COVID-19 Landscape: Neonatal Ventilators Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Neonatal Ventilators Market, By Product

8.1. Neonatal Ventilators Market Revenue and Volume, by Product, 2024-2034

8.1.1. Invasive Ventilation

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Non-invasive Ventilation

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Neonatal Ventilators Market, By Mobility

9.1. Neonatal Ventilators Market Revenue and Volume, by Mobility, 2024-2034

9.1.1. Intensive Care Ventilators

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Portable/Transportable Ventilators

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Neonatal Ventilators Market, By Technology 

10.1. Neonatal Ventilators Market Revenue and Volume, by Technology, 2024-2034

10.1.1. Mechanical Ventilators

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. High Frequency Ventilators

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Volume Targeted Ventilators

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

10.1.4. Hybrid Ventilators

10.1.4.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Neonatal Ventilators Market, By Mode

11.1. Neonatal Ventilators Market Revenue and Volume, by Mode, 2024-2034

11.1.1. Pressure Mode Ventilation

11.1.1.1. Market Revenue and Volume Forecast (2021-2034)

11.1.2. Combined Mode Ventilation

11.1.2.1. Market Revenue and Volume Forecast (2021-2034)

11.1.3. Volume Mode Ventilation

11.1.3.1. Market Revenue and Volume Forecast (2021-2034)

11.1.4. Other Modes

11.1.4.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 12. Global Neonatal Ventilators Market, By End-use

12.1. Neonatal Ventilators Market Revenue and Volume, by End-use, 2024-2034

12.1.1. Hospitals

12.1.1.1. Market Revenue and Volume Forecast (2021-2034)

12.1.2. Clinics

12.1.2.1. Market Revenue and Volume Forecast (2021-2034)

12.1.3. Ambulatory Surgical Centers

12.1.3.1. Market Revenue and Volume Forecast (2021-2034)

12.1.4. Other End-users

12.1.4.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 13. Global Neonatal Ventilators Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.1.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.1.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.1.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.1.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.1.6.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.1.6.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.1.6.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.1.6.5. Market Revenue and Volume Forecast, by End-use (2021-2034) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.1.7.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.1.7.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.1.7.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.1.7.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.2.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.2.4. Market Revenue and Volume Forecast, by Mode (2021-2034) 

13.2.5. Market Revenue and Volume Forecast, by End-use (2021-2034) 

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.6.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.2.6.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.2.7. Market Revenue and Volume Forecast, by Mode (2021-2034) 

13.2.8. Market Revenue and Volume Forecast, by End-use (2021-2034) 

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.9.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.2.9.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.2.10. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.2.11. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.12.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.2.12.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.2.12.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.2.13. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.14.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.2.14.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.2.14.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.2.15. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.3.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.3.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.3.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.6.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.3.6.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.3.6.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.3.7. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.8.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.3.8.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.3.8.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.3.9. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.10.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.3.10.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.3.10.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.3.10.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.11.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.3.11.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.3.11.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.3.11.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.4.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.4.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.4.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.6.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.4.6.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.4.6.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.4.7. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.8.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.4.8.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.4.8.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.4.9. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.10.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.4.10.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.4.10.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.4.10.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.11.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.4.11.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.4.11.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.4.11.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.5.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.5.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.5.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.5.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.5.6.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.5.6.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.5.6.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.5.7. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.5.8.2. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.5.8.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.5.8.4. Market Revenue and Volume Forecast, by Mode (2021-2034)

13.5.8.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

Chapter 14. Company Profiles

14.1. Air Liquide

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Becton Dickinson

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Breas Medical

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Drägerwerk AG & Co. KGaA

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Getinge Group

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Medtronic plc

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. ICU Medical

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. GE Healthcare

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. HAMILTON MEDICAL

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Koninklijke Philips N.V

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client